Excellence in clinical research from A to Z

Scroll down ⇩

About us

AtoZ-CRO GmbH is a full-service clinical research organisation (CRO) located in Overath near Cologne, Germany, with over 30 years of experience in clinical development and clinical study management. As a specialist for Germany, Europe, the US, and India, AtoZ-CRO offers a broad range of professional services and partner solutions for international clinical studies with pharmaceuticals and medical devices.


From its head office located in Overath, Germany, AtoZ-CRO manages and coordinates clinical studies of phase 0 through phase IV for national and international clients. The company forms a team of 35 highly experienced and dedicated industry professionals and medical specialists ensuring high standards in clinical study management. AtoZ-CRO is affiliated with a leading initiator of phase I studies in Warsaw, Poland.


Based on the company’s long-established international experience in clinical trial management and cooperation with high-rated business partners, AtoZ-CRO is proud to offer a broad range of services covering all clinical research needs, in particular for small and mid-sized pharmaceutical, biotech, and medical device companies.

Clinical Studies 

Contact us

Clinical Studies

Clinical Studies Phases 0 – IV

  • Planning of clinical studies
  • Preparation of study protocols
  • Design and implementation of CRFs (case report forms) and eCRFs
  • Processing of applications for ethical votes and permissions (e.g. CTA, IND)
  • Regulatory affairs issues
  • Legal EU representative

Other services

  • Monitoring
  • Post-marketing studies

-  NIS

-  PASS

-  Epidemiology

  • Pharmacovigilance
  • Biometry
  • Medical Writing and Translations

About us

Contact us

Contact us

AtoZ-CRO GmbH

Hauptstr. 77
51491 Overath
Tel: 02206 95 99 0
Fax: 02206 820 63
Email: info@atoz-cro.de
www.atoz-cro.de

Business Development

Dr. med. Karl-Peter Klein | Managing Director
Email: kp.klein@atoz-cro.de

Back to top ⇧

Go to article: Home | The future of MRI machinesGo to article: In this issueGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: ContentsGo to article: Protomatic Medical Company InsightGo to article: Protomatic MedicalGo to article: NewsGo to article: MPS Microsystems Company InsightGo to article: MPS MicrosystemsGo to article: The Medical Industry BriefingGo to article: MikronGo to article: Is the US medical device excise tax back for good?Go to article: IMT Company InsightGo to article: IMTGo to article: The effect of value-based care on the medical devices industryGo to article: Micro Systems TechnologiesGo to article: Abbott GmbH & CoGo to article: New patch aims to convert energy-storing fats into energy-burning fatsGo to article: Accurate Biometrics Company InsightGo to article: Accurate BiometricsGo to article: Medtronic to challenge Penumbra with new aspiration retrieverGo to article: Freudenberg MedicalGo to article: Mitral valve repair: the next frontierGo to article: AtoZ-CRO GmbH Company InsightGo to article: AtoZ-CRO GmbHGo to article: Detecting language problems: a tech-assisted vision for earlier diagnosisGo to article: Democratising data: the key to better healthcare?Go to article: GF Machining Solutions Company InsightGo to article: GF Machining Solutions Go to article: The critical moment: can machine learning save lives in sepsis care?Go to article: Exploring the past and future of MRI with AvingtransGo to article: Tricor SystemsGo to article: The high-tech hunt for new biomarkersGo to article: Braxton Manufacturing Go to article: Earl Bakken and the story of MedtronicGo to article: EventsGo to article: Next issue